Skip to main content
. 2021 Feb 28;13(5):1008. doi: 10.3390/cancers13051008

Table 1.

Main characteristics of patients with cervical cancer undergoing FSS.

LLETZ/CKC/ST VRT ART
Laparotomic MIS
Study/patient characteristics
n of studies 29 31 28 10
Total n of patients 2540 2477 2268 566
n of patients excluded # 108 76 91 32
Age (y), median (range) 32 (22–46) 31 (21–42) 32 (22–40) 31 (22–40)
Tumor characteristics ^ n of patients (%) n of patients (%) n of patients (%) n of patients (%)
FIGO stage *
IA1 1551 (60.4) 248 (9.0) 165 (7.1) 13 (2.4)
IA2 547 (21.3) 311 (11.3) 218 (9.4) 50 (9.3)
IA-IB 0 230 (8.4) 143 (6.2) 0
IB1 452 (17.6) 1933 (70.3) 1723 (74.6) 453 (84.0)
IB2 18 (0.7) 3 (0.1) 20 (0.9) 3 (0.6)
IB nos 0 0 17 (0.7) 19 (3.5)
IIA 2 (0.1) 26 (0.9) 25 (1.1) 1 (0.2)
Histological subtype
SCC 2316 (82.2) 1906 (67.9) 1689 (72.4) 339 (63.2)
AC 467 (16.6) 770 (27.4) 518 (22.2) 169 (31.5)
ASCC 25 (0.9) 86 (3.1) 84 (3.6) 12 (2.2)
Other 8 (0.3) 47 (1.7) 43 (1.8) 16 (3.0)
LVSI~ 150/784 (19.1) 586/1877 (31.2) 657/1628 (40.4) 59/341 (17.3)

FSS—fertility-sparing surgery; LLETZ—large loop excision of transformation zone; CKC—cold knife conization; ST—simple trachelectomy; VRT—vaginal radical trachelectomy; ART—abdominal radical trachelectomy; MIS—minimal invasive surgery (laparoscopic or robot-assisted); SCC—squamous cell carcinoma; AC—adenocarcinoma; ASCC—adenosquamous cell carcinoma; LVSI—lymph-vascular space invasion; nos—not otherwise specified; # No FSS due to positive lymph nodes/margins or other reasons contraindicating FSS; ^ In some studies, this also includes excluded patients or patients who underwent other types of FSS if data were not reported separately; therefore, the n of patients could exceed the total n of patients; * FIGO 2009 classification was used in all but one study, which used FIGO 2018 (n = 32); ~limited to publications with available data.